Baxter International Inc. (BAX)
NYSE · Healthcare
Baxter International Inc. EBITDA 2007–2025
Baxter International Inc. annual/quarterly ebitda history and growth rate from 2013 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Baxter International Inc. ebitda for the quarter ending March 31, 2026 was 303.0 M, a 0.66% decrease year-over-year.
- Baxter International Inc. ebitda for the twelve months ending March 31, 2026 was 1.4 B, a 38.45% decrease year-over-year.
- Baxter International Inc. annual ebitda for 2025 was 673.0 M, a 33.43% decrease from 2024.
- Baxter International Inc. annual ebitda for 2024 was 1.0 B, a 40.21% decrease from 2023.
- Baxter International Inc. annual ebitda for 2023 was 1.7 B, a 195.38% decrease from 2022.
- Baxter International Inc. annual ebitda for 2022 was -1.8 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Baxter International Inc. EBITDA — FAQ
Baxter International Inc. (BAX) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BAX's ebitda history?
The chart and table above show Baxter International Inc.'s ebitda by year and by quarter, including the growth rate.